课题基金 / 基金详情

A Hub for the Nuclear Receptor Signaling Atlas1

A Hub for the Nuclear Receptor Signaling Atlas1
核受体信号图谱的枢纽1
批准号:
8441145
负责人:
RONALD M EVANS
金额:
$150.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-17 至 2017-08-31

项目摘要

项目成果

RONALD M EVANS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over the past decade the field of NR signaling has generated a large volume of global datasets that collectively describe sequences of NR and coregulator genes (genomics); the regulation by NRs and coregulators of gene networks in specific target tissues (transcriptomics); protein-protein interactions required for the efficient function of NRs and coregulators (proteomics); specific sites of action of NRs in target gene promoters (cistromics); covalent modification of chromatin (epigenomics); and, more recently, specific functional endpoints in the form of regulation of cellular metabolic pathways (metabolomics). In order to effectively leverage these resources, we propose the continued development of the Nuclear Receptor Signaling Atlas (NURSA) web resource that will assemble and integrate these datasets, build user-friendly data analysis tools and present these to the community for hypothesis generation and validation. To fully engage the research community, we propose to administer a program of NURSA Data Source Projects (NDSPs) that will generate new global scale datasets that will be submitted to the website and integrated with existing datasets. We will also engage in outreach efforts that will offer members of the research community to participate in NURSA as Affiliate members, as well as in testing software tools during their development. With the involvement of the community, we anticipate that NURSA will be an important research resource for this field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
Tissue-specific roles of FXR in CVD and NASH
Tissue-specific roles of FXR in CVD and NASH
Tissue-specific roles of FXR in CVD and NASH
海外基金